Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma

Human Pathology

Volumn 38, Issue 10, 2007, Pages 1576-1580

  Alsop, Skylar ^a   Sanger, Warren G ^b   Elenitoba Johnson, Kojo S J ^c   Lim, Megan S ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Anaplastic large cell lymphoma; Chronic myeloid leukemia; Therapy

Indexed keywords

ASPARAGINASE MACROGOL; CYCLOPHOSPHAMIDE; DAUNORUBICIN; PREDNISONE; TRANSFORMING GROWTH FACTOR; VINCRISTINE;

ADOLESCENT; ANAPLASTIC CARCINOMA; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 2; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LEG EDEMA; LEUKOCYTE COUNT; MALE; MYELOPROLIFERATIVE DISORDER; ORBIT TUMOR; PERIPHERAL BLOOD MONONUCLEAR CELL; RARE DISEASE; TISSUE SECTION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; DAUNORUBICIN; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LYMPHOMA, LARGE-CELL; MALE; NEOPLASMS, SECOND PRIMARY; ORBITAL NEOPLASMS; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VINCRISTINE;

EID: 34548672371     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.05.018     Document Type: Article

References (9)

1. Perkins S.L. Work-up and diagnosis of pediatric non-Hodgkin's lymphomas. Pediatr Dev Pathol 3 (2000) 374-390
2. Pittaluga S., Wlodarska I., Pulford K., et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 151 (1997) 343-351
3. Morris S.W., Kirstein M.N., Valentine M.B., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263 (1994) 1281-1284
4. Gascoyne R.D., Aoun P., Wu D., et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 93 (1999) 3913-3921
5. Ries L., Smith M., Gurney J., et al. Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995 (1999), National Cancer Institute, SEER Program, Bethesda (MD)
6. Tronnier M., and Merz H. Anaplastic large cell lymphoma and keratoacanthoma. Hautarzt 55 (2004) 182-185
7. Aguiar R.C. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk Lymphoma 29 (1998) 17-26
8. Numata A., Shimoda K., Gondo H., et al. Therapy-related chronic myelogenous leukaemia following autologous stem cell transplantation for Ewing's sarcoma. Br J Haematol 117 (2002) 613-616
9. Specchia G., Buquicchio C., Albano F., et al. Non-treatment-related chronic myeloid leukemia as a second malignancy. Leuk Res 28 (2004) 115-119